Skip to content

Effect of a Simulated Flight in Patients With Type 2 Diabetes and Healthy Volunteers

Modelling Endothelial Function With Hypoxia and Low Humidity (Simulated Flight Environment) in Healthy Volunteers and Patients With Type 2 Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04031417
Acronym
FlyBar
Enrollment
20
Registered
2019-07-24
Start date
2013-03-31
Completion date
2015-01-31
Last updated
2022-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Brief summary

Diabetes is an increasingly common condition which affects millions of people in the United Kingdom. Patients with type 2 diabetes are at increased risk to develop severe heart disease and vascular complications and these can result in death. A cornerstone of the treatment is lifestyle and diet. The number of travellers is increasing quickly and there are more people than ever travelling by airplane. During a commercial flight the pressure of the air is lower than the pressure on the surface and that results in lower concentration of oxygen in the air we are breathing while flying. Also the humidity is very low inside an aircraft. The aims of this study are to show if we can use a simulated flight as a method to look at how the endothelial cells react and to see if this is different between patients with type 2 diabetes mellitus and healthy volunteers. A sub-study is also incorporated to look at different dietary interventions in type 2 diabetes.

Interventions

OTHERHypoxia

Sponsors

Hull University Teaching Hospitals NHS Trust
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
45 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

Diabetes group: * Diagnosis of type 2 diabetes * Patients on stable medication (for their diabetes metformin being the only treatment if any), for 3 months prior to entry into the study * Age between 45-75 years at the start of the study; women need to be postmenopausal and not undergoing hormone replacement therapy (HRT) Healthy volunteers group: * No current disease or medication which would have effect on the safety of the subjects or interfere with the study results * Age between 45-75 years at the start of the study; women need to be postmenopausal and not undergoing HRT

Exclusion criteria

* For both groups: * Patients with concurrent illness or any medication in the last 3 months that would interfere with the study based on the investigator's judgement * Acute coronary syndrome in the last 3 months or any major clinical event in the previous 3 months that would effect the study based on the investigator's judgement * Patients not wishing to allow disclosure to their general practitioner (GP)s. * HbA1c \>9% * Smokers * Pre-menopausal women or post-menopausal women on HRT * Claustrophobia, panic attacks in the anamnesis * Subjects must not have been subjected to a commercial flight within 4 weeks of the study

Design outcomes

Primary

MeasureTime frameDescription
Hypoxia and low humidity on the endothelial function in healthy volunteers and patients with type 2 diabetes using Wilcoxon signed rank testChange from Baseline to 2 hoursTo determine the effect of hypoxia and low humidity on the endothelial function in healthy volunteers and patients with type 2 diabetes

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026